Search results
Justice Dept plans to reschedule marijuana as a lower-risk drug
Plus via Yahoo News· 2 days agoThe expected recommendation comes after the US Health and Human Services department, following a...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 4 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
DEA will move to reclassify marijuana as a less-dangerous drug
San Jose Mercury News· 5 days agoThe U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug,...
DEA plans to reschedule marijuana as a lower-risk drug
ABC12 Mid-Michigan· 5 days agoThe Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a...
Biden officials indefinitely postpone ban on menthol cigarettes amid election-year pushback
WINK TV Southwest Florida· 6 days agoPresident Joe Biden’s administration is indefinitely delaying a long-awaited menthol cigarette ban,...
Menthol cigarette ban postponed by Biden officials
FOX News Chicago· 7 days agoA long-awaited menthol cigarette ban has been once again postponed by President Joe Biden’s administration. The Food
As presidential election race tightens, outlook dims for Biden signing menthol traditional cigarette...
Greensboro News & Record· 6 days agoThe potential of the Biden administration signing off on a proposed ban on menthol-flavored...
What does marijuana reclassification mean for US?
WJZY via Yahoo News· 4 days ago“When the dust has settled, I don’t know how many years from now, research will be easier.” Among the unknowns: whether researchers will be able to study...
Don't like this economy? OK, just wait for Trump and the GOP to ruin it
Salon via Yahoo Finance· 20 hours agoAnd Republicans' fallback argument that they are better with the annual deficit or the national debt...
US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
Pittsburgh Tribune-Review· 4 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...